BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 1658173)

  • 1. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
    Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
    J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of elastase and cathepsin G in Chédiak-Higashi (beige) neutrophils.
    Takeuchi KH; Swank RT
    J Biol Chem; 1989 May; 264(13):7431-6. PubMed ID: 2708370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
    Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
    Boudier C; Cadène M; Bieth JG
    Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
    Pratt CW; Tobin RB; Church FC
    J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.
    Steinmeyer J; Kalbhen DA
    Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function, and control of neutrophil proteinases.
    Travis J
    Am J Med; 1988 Jun; 84(6A):37-42. PubMed ID: 2454577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, Hageman factor fragments, and other serine proteinases.
    Hojima Y; Pisano JJ; Cochrane CG
    Biochem Pharmacol; 1983 Mar; 32(6):985-90. PubMed ID: 6340694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases.
    Owen CA; Campbell MA; Sannes PL; Boukedes SS; Campbell EJ
    J Cell Biol; 1995 Nov; 131(3):775-89. PubMed ID: 7593196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.
    Bangalore N; Travis J
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):659-66. PubMed ID: 7888078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
    Goldstein W; Döring G
    Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal elastase and cathepsin G in beige mice. Neutrophils of beige (Chediak-Higashi) mice selectively lack lysosomal elastase and cathepsin G.
    Takeuchi K; Wood H; Swank RT
    J Exp Med; 1986 Mar; 163(3):665-77. PubMed ID: 3512758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various properties of cathepsin G and elastase from swine peripheral blood neutrophils].
    Kraeva LN; Kokriakov VN; Chesnokov IN; Iakovleva MF; Lyzlova SN
    Biokhimiia; 1988 Apr; 53(4):655-62. PubMed ID: 3395645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
    Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
    J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
    Adam C; Bieth JG
    FEBS Lett; 1996 May; 385(3):201-4. PubMed ID: 8647251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
    Petersen LC; Bjørn SE; Nordfang O
    Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-mediated proteolysis. Differential roles for cathepsin G and elastase.
    Kubes P; Smith R; Grisham MD; Granger DN
    Inflammation; 1993 Jun; 17(3):321-32. PubMed ID: 8330930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives.
    Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P
    Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.